ginsenoside rh2 has been researched along with Aura in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M; Li, S; Wang, S; Wu, J; Zhao, W | 1 |
1 other study(ies) available for ginsenoside rh2 and Aura
| Article | Year |
|---|---|
Ginsenoside Rh2 inhibits CBP/p300-mediated FOXO3a acetylation and epilepsy-induced oxidative damage via the FOXO3a-KEAP1-NRF2 pathway.
Topics: Acetylation; Anticonvulsants; CREB-Binding Protein; Epilepsy; Humans; Kelch-Like ECH-Associated Protein 1; Neuroblastoma; NF-E2-Related Factor 2; Oxidative Stress | 2023 |